Author:
Dekker Nicky,van Dorst Eleonora B. L.,van der Luijt Rob B.,van Gijn Marielle E.,van Tuil Marc,Offerhaus Johan A.,Ausems Margreet G. E. M.
Reference73 articles.
1. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., et al. (1999). Cancer risks in mutation carriers of DNA-mismatch-repair genes. International Journal of Cancer, 81(2), 214–218.
2. American Society of Clinical Oncology. (2003). Statement of the American Society of Clinical Oncology policy statement update: Genetic Testing for Cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.
3. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention, 9(11), 1251–1254.
4. Auranen, A., & Joutsiniemi, T. (2011). A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. ACTA Obstetricia et Gynecologica Scandinavica, 90(5), 437–444.
5. Backes, F. J., Hampel, H., Backes, K. A., Vaccarello, L., Lewandowski, G., Bell, J. A., et al. (2009). Are prediction models for Lynch syndrome valid for probands with endometrial cancer? Familial Cancer, 8(4), 483–487.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献